BSECompany Update25 Aug 2026 · 25 Aug 2026, 05:18 pm
Intimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August, 2026
Sai Parenterals Ltd · 544742
✦ AI Summary
Sai Parenterals Ltd has announced an analyst/institutional investor meeting on August 31, 2026, to be held in Mumbai. The meeting will be in person and hosted by Strategic Growth Advisors Pvt. Ltd. No unpublished price-sensitive information will be shared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
0e5e8109-dd66-401a-9b86-0dd37445f1c1.pdf
View document text
Date: 25.08.2026
The Manager The Manager,
BSE Limited NSE Limited,
P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex,
Mumbai-400001 Bandra (E), Mumbai- 400051.
(BSE Scrip Code: 544742) (NSE Symbol: SAIPARENT)
Dear Sir/Madam,
Unit: Sai Parenterals Limited
Subject: Intimation of Schedule of Analyst / Institutional Investor meetings
Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time,
we would like to inform you that the Management and/or Officials of Sai Parenteral’s Limited will be
participating and interacting in an Analyst/Institutional Investor Meeting. The details are as follows:
S. No Particulars Details
1. Date of Meeting Monday, 31st August, 2026
2. Mode of Meeting In Person/Physical
3. Type of Meeting Group Meeting
4. Venue of Meeting Mumbai
5. Time of Meeting 10:00 AM Onwards
6. Hosted by Strategic Growth Advisors Pvt. Ltd.
The discussions during the meeting will be limited to publicly available information, and no
unpublished price sensitive information (UPSI) will be shared or discussed.
Please note that the above schedule is subject to change due to exigencies on the part of the Host
and/or the Company.
Kindly take the above information on record.
Thanking you,
Yours faithfully,
For Sai Parenterals Limited
Mr. Anil Kumar Karusala
Managing Director
(DIN- 01866646)